Brick, Rachelle S.
Gallicchio, Lisa
Mollica, Michelle A.
Zaleta, Alexandra K.
Tonorezos, Emily S.
Jacobsen, Paul B.
Castro, Kathleen M.
Miller, Melissa F. http://orcid.org/0000-0001-7099-7799
Article History
Received: 5 January 2024
Accepted: 17 March 2024
First Online: 9 April 2024
Declarations
:
: Ethical and Independent Review Services (E&I, Independence, MO) served as the IRB of record (Study #23044). All procedures were in accordance with the ethical standards of the institutional research committee for studies involving human participants and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all participants.
: Dr. Zaleta reports conducting research in the past two years funded by: Astellas Pharma, Boston Scientific Foundation, Novartis, and Seagen; funding was received by Cancer Support Community. Dr. Miller reports institutional research grants from Astellas Pharma, BeiGene, Bristol Myers Squibb, Genentech, Geron, Gilead Sciences, GSK, Janssen Oncology, Merck, Novartis, Pfizer, Seagen, Taiho Oncology, and Takeda Oncology.